Author: Staff

The global market for cervical total disc replacement devices will surpass $1 billion by 2021, according to a Persistence Market Research report.

The Centers for Musculoskeletal Disorders in Englewood, N.J., installed Mazor Robotics' Renaissance system.

The Therapeutic Goods Administration of Australia approved AxioMed's Freedom Viscoelastic Disc Replacement technology.

Zimmer Biomet Spine will present clinical data on its Aspen MIS Fusion System and the Timberline Systems at the Congress of Neurological Surgeons' annual meeting.

New York City-based Maimonides Medical Center appointed John K. Houten, MD, the new director of spinal neurosurgery and neurotrauma.

Here five spine surgeons weigh in on what needs to change in the U.S. health insurance industry.

What is the mortality risk for patients with vertebral compression fractures, and how do the mortality risk and morbidly risk vary for treating VCF patients with non-surgical management, vertebroplasty or balloon kyphoplasty?

Since entering private practice nearly five years ago, orthopedic surgeon Stephen Kayiaros, MD, has seen the industry significantly change.

In the hustle and bustle of surgeons' daily schedules, there are certain moments that resonate as pivotal experiences that changed their careers.

A new study published in The Journal of Bone and Joint Surgery examines cervical spine arthrodesis and the factors affecting long-term revision rates.